Experts question continuation of Covishield vaccine trials in India despite adverse event report
Censure SII’s move to file a defamation suit on the participant who reported the adverse event, stating that it will discourage…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Malini Aisola
Experts seek data on remdesivir and COVID-19 treatment-related products
Ask for details of specific indications for which approval has been granted, any conditions or restrictions attached to the…
NPPA dismisses AstraZeneca’s plea and fixes retail price Dapagliflozin + Metformin formulation…
On the grounds that it is a pricing authority and cannot decide on patents, the National Pharmaceutical Pricing Authority (NPPA)…
Government has not yet decided to make UCPMP mandatory: DV Sadananda Gowda
Under UCPMP there is no provision for the DoP to directly deal with complaints received regarding unethical practices